Harnessing Adherence Cartography for Enhanced Patient Care

Our Services

At Adherence, we are redefining what it means to understand, measure, and predict medication behavior.

Our approach is built on next-generation tools that go beyond self-report and into the core of behavioral instability tools like the BAS-8™ (Behavioral Adherence Stability Scale) and the Behavioral Fragility Score (BFS), which together uncover early signs of adherence deterioration before outcomes are affected.

Where other systems react to nonadherence after it happens, we offer a new kind of intelligence which is predictive, behaviorally grounded, and clinically actionable.

Ξxpert™ is the official certification system for behavioral adherence science. It trains clinicians, researchers, and system leaders in how to detect, measure, and respond to behavioral fragility using the BAS-8™, BFS, and MMAS frameworks. With three distinct levels: Introductory, Core, and Pro—Ξxpert delivers a progression of mastery:

• From accurate scoring and research fidelity,
   
• To minimum-standard behavioral interventions,
   
• To advanced modeling of instability and resilience.
   

It is the only training program that prepares users to predict adherence collapse, rather than just measure it.

In modern clinical research, adherence must be more than a binary variable.

Adherence integrates the BAS-8™ and MMAS-8R as tools for assessing behavioral stability, fragility, and pattern-specific nonadherence. Whether used as exploratory endpoints or embedded in behavioral sub study arms, these instruments allow sponsors to:

• Detect behavioral risk,
   
• Segment participants by fragility level,
   
• And generate a Behavioral Fragility Score (BFS) to model the likelihood of adherence failure over time.
   

This enables fidelity-preserving, behaviorally stratified trials with deeper insight into patient behavior and therapeutic outcomes.

Adherence tools can now travel with the patient.

Through digital integration, the BAS-8™ and MMAS can be administered in real time during telehealth visits or medication therapy management (MTM) check-ins allowing providers to:

• Identify early signs of behavioral fragility,
   
• Intervene before nonadherence occurs,
   
• And track the impact of remote interventions over time.
   

Our Excel-embedded tools and API-ready platforms make behavioral adherence measurable, even between visits.

Transitions in care like hospital discharge are moments of risk, where adherence often fails silently.

We embed the BAS-8™ into intake, discharge, and transition protocols to identify behavioral fragility before the patient leaves the facility. When needed, the MMAS-8R follows to further classify the type of nonadherence and generate a complete Behavioral Fragility Score (BFS).

This layered approach enables care teams to deliver tailored, behaviorally aligned interventions from day one, reducing readmissions, increasing engagement, and anchoring patients in their new routines.

ATLAS™ is our global behavioral intelligence platform, built to detect and map adherence fragility at the population level. By aggregating BAS-8™, MMAS, and BFS data across geographies and demographics, ATLAS enables:

• Early identification of adherence hotspots,
   
• Behavioral segmentation of populations,
   
• And data-driven targeting of health resources before gaps widen.
   

Whether for public health response, pharmaceutical field strategy, or academic insight, ATLAS transforms raw adherence data into predictive behavioral cartography.

Our services do not simply integrate adherence tools, they redefine how adherence is seen and supported.

By placing the BAS-8™ and BFS at the forefront, with MMAS-8R as a complementary classification layer, we help systems move from reactive to predictive, from static to dynamic, and from compliance-based to behaviorally grounded.

Join us in building the future of adherence, where behavior is no longer a black box and where patients are supported before they fall.